The long-acting reversible contraceptive, Sayana Press, has received a licence which means women can inject themselves at home instead of having to go to their GP surgery or clinic.
The Medicines and Healthcare Products Regulatory Agency (MHRA) has extended the label for the product. Each jab provides contraception for at least 13 weeks.
Seema Patel, medical director of global established pharma UK at Pfizer, said: “When it comes to contraception, women may require different options that suit them at different times in their lives.
“We appreciate that many women are very busy and that visiting their healthcare professional regularly to pick up their contraception can be a challenge.
“With around five million women in the UK choosing a hormonal contraceptive, self-injectable Sayana Press could offer an alternative to women who are short on time yet still want to take control of their family planning.”
Among teenagers aged 12 to 18, Sayana Press is only to be issued when other contraceptive methods are considered unsuitable or unacceptable, according to Pfizer.
A year’s supply of the contraceptive can be supplied in one go by health workers.